A new buyout round for DOC Generici. ICG buys the group from CVC. It’s a 1.1 bn euro deal

Intermediate Capital Group (ICG) will acquire the Italian pharmaceutical group Doc Generici so far in the portfolio of CVC Capital. it was announced by ICG this morning (see here the press release), confirming the news reported by Bloomberg a few days ago. The pool of lending banks would include Unicredit, Bnp Paribas, Credit Agricole and Barclays, while the deal's legal advisors have been Gattai Minoli Agostinelli and Legance. White&Case supported Mérieux from the legal standpoint, whileCVC was supported by Legance from the lìlegal perspective and from e Facchini Rossi & soci from the fiscal perspective. The transaction is said to be worth 1.1 billion euros, considering that FY 2018 saw revenues exceed 200 million